Drug Bioequivalence

PDF Version Also Available for Download.

Description

Report of the findings from a panel of the Office of Technology Assessment (OTA) regarding drug bioequivalence therapies. According to the report, the purpose of the Drug Bioequivalence Study Panel "was to examine the relationships between the chemical and therapeutic equivalence of drug products and to assess the capability of current technology -- short of therapeutic trials in man -- to determine whether drug products with the same physical and chemical composition produce comparable therapeutic effects" (p. 5).

Physical Description

78 p. ; 28 cm.

Creation Information

United States. Congress. Office of Technology Assessment. Drug Bioequivalence Study Panel. July 1974.

Context

This report is part of the collection entitled: Office of Technology Assessment and was provided by UNT Libraries Government Documents Department to Digital Library, a digital repository hosted by the UNT Libraries. It has been viewed 153 times . More information about this report can be viewed below.

Who

People and organizations associated with either the creation of this report or its content.

Provided By

UNT Libraries Government Documents Department

Serving as both a federal and a state depository library, the UNT Libraries Government Documents Department maintains millions of items in a variety of formats. The department is a member of the FDLP Content Partnerships Program and an Affiliated Archive of the National Archives.

Contact Us

What

Descriptive information to help identify this report. Follow the links below to find similar items on the Digital Library.

Description

Report of the findings from a panel of the Office of Technology Assessment (OTA) regarding drug bioequivalence therapies. According to the report, the purpose of the Drug Bioequivalence Study Panel "was to examine the relationships between the chemical and therapeutic equivalence of drug products and to assess the capability of current technology -- short of therapeutic trials in man -- to determine whether drug products with the same physical and chemical composition produce comparable therapeutic effects" (p. 5).

Physical Description

78 p. ; 28 cm.

Notes

The original does not have a page 4.

Language

Item Type

Collections

This report is part of the following collection of related materials.

Office of Technology Assessment

The Office of Technology Assessment (OTA) operated from 1972 to 1995, providing Congressional members and committees with analyses of the scientific and technological issues that were increasingly relevant to public policy and legislative action. This collection includes quarterly and annual reports, as well as internal OTA documents such as orientation materials. Many other interesting OTA materials are available in the OTA Legacy Collection via the CyberCemetery.

What responsibilities do I have when using this report?

When

Dates and time periods associated with this report.

Creation Date

  • July 1974

Coverage Date

Added to The UNT Digital Library

  • Aug. 20, 2011, 9:15 p.m.

Description Last Updated

  • April 1, 2016, 1:17 p.m.

Usage Statistics

When was this report last used?

Yesterday: 0
Past 30 days: 1
Total Uses: 153

Where

Geographical information about where this report originated or about its content.

Place Name

Publication Place

Map Information

  • map marker Automatically generated Place Name coordinates.
  • map marker Automatically generated Publication Place coordinates.
  • Repositioning map may be required for optimal printing.

Mapped Locations

Interact With This Report

Here are some suggestions for what to do next.

Start Reading

PDF Version Also Available for Download.

Citations, Rights, Re-Use

United States. Congress. Office of Technology Assessment. Drug Bioequivalence Study Panel. Drug Bioequivalence, report, July 1974; [Washington D.C.]. (digital.library.unt.edu/ark:/67531/metadc39335/: accessed October 22, 2017), University of North Texas Libraries, Digital Library, digital.library.unt.edu; crediting UNT Libraries Government Documents Department.